{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:25:38Z","timestamp":1784053538148,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,24]]},"DOI":"10.7759\/cureus.56810","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T10:23:25Z","timestamp":1711275805000},"source":"Crossref","is-referenced-by-count":4,"title":["C-peptide Level in Patients With Uncontrolled Type 2 Diabetes Mellitus on Oral Anti-diabetic Drugs"],"prefix":"10.7759","author":[{"given":"Purnendu","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrapani","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ved","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saajid","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harihar","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Type 2 Diabetes","author":"Goyal R","year":"2024","unstructured":"Goyal R, Singhal M, Jialal I. Type 2 Diabetes. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","article-title":"Biochemistry, C Peptide","author":"Venugopal SK","year":"2024","unstructured":"Venugopal SK, Mowery ML, Jialal I. Biochemistry, C Peptide. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress","volume":"14","author":"Dludla PV","year":"2023","unstructured":"Dludla PV, Mabhida SE, Ziqubu K, et al.. Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress. World J Diabetes. 2023, 14:130-46. 10.4239\/wjd.v14.i3.130","journal-title":"World J Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3514","article-title":"C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: a real-world study","volume":"38","author":"Huang Y","year":"2022","unstructured":"Huang Y, Wang Y, Liu C, et al.. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: a real-world study. Diabetes Metab Res Rev. 2022, 38:e3514. 10.1002\/dmrr.3514","journal-title":"Diabetes Metab Res Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.21.1.14","article-title":"Clarifying the role of insulin in type 2 diabetes management","volume":"21","author":"White JR Jr","year":"2003","unstructured":"White JR Jr, Davis SN, Cooppan R, et al.. Clarifying the role of insulin in type 2 diabetes management. Clin Diabetes. 2003, 21:14-21. 10.2337\/diaclin.21.1.14","journal-title":"Clin Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2020.1771047","article-title":"Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications","volume":"132","author":"Wysham C","year":"2020","unstructured":"Wysham C, Shubrook J. Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgrad Med. 2020, 132:676-86. 10.1080\/00325481.2020.1771047","journal-title":"Postgrad Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton E","year":"2017","unstructured":"Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017, 8:475-87. 10.1007\/s13300-017-0265-4","journal-title":"Diabetes Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4158\/EP15672.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015","volume":"21","author":"Handelsman Y","year":"2015","unstructured":"Handelsman Y, Bloomgarden ZT, Grunberger G, et al.. American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015, 21:1-87. 10.4158\/EP15672.GL","journal-title":"Endocr Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00425-6","article-title":"The trials and tribulations of determining HbA1c targets for diabetes mellitus","volume":"16","author":"Klein KR","year":"2020","unstructured":"Klein KR, Buse JB. The trials and tribulations of determining HbA1c targets for diabetes mellitus. Nat Rev Endocrinol. 2020, 16:717-30. 10.1038\/s41574-020-00425-6","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.11.010","article-title":"C-peptide concentrations in patients with type 2 diabetes treated with insulin","volume":"13","author":"Uzunlulu M","year":"2019","unstructured":"Uzunlulu M, Oguz A, Arslan Bahadir M, Erbakan AN, Vural Keskinler M, Alpaslan Mesci B. C-peptide concentrations in patients with type 2 diabetes treated with insulin. Diabetes Metab Syndr. 2019, 13:3099-104. 10.1016\/j.dsx.2019.11.010","journal-title":"Diabetes Metab Syndr"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.33314\/jnhrc.v16i41.1560","article-title":"Correlation of blood pressure with body mass index, waist circumference and waist by hip ratio","volume":"16","author":"Chaudhary S","year":"2019","unstructured":"Chaudhary S, Alam M, Singh S, Deuja S, Karmacharya P, Mondal M. Correlation of blood pressure with body mass index, waist circumference and waist by hip ratio. J Nepal Health Res Counc. 2019, 16:410-3.","journal-title":"J Nepal Health Res Counc"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease","volume":"44","author":"U.K. Prospective Diabetes Study Group","year":"1995","unstructured":"U.K. Prospective Diabetes Study Group. U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes. 1995, 44:1249-58.","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422366","article-title":"Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects","volume":"38","author":"Mykk\u00e4nen L","year":"1995","unstructured":"Mykk\u00e4nen L, Haffner SM, Kuusisto J, Py\u00f6r\u00e4l\u00e4 K, Hales CN, Laakso M. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia. 1995, 38:1176-82. 10.1007\/BF00422366","journal-title":"Diabetologia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01585.x","article-title":"Hyperproinsulinaemia and risk of type 2 diabetes mellitus in women","volume":"22","author":"Schulze MB","year":"2005","unstructured":"Schulze MB, Solomon CG, Rifai N, Cohen RM, Sparrow J, Hu FB, Manson JE. Hyperproinsulinaemia and risk of type 2 diabetes mellitus in women. Diabet Med. 2005, 22:1178-84. 10.1111\/j.1464-5491.2005.01585.x","journal-title":"Diabet Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1433","article-title":"Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men","volume":"27","author":"Zethelius B","year":"2004","unstructured":"Zethelius B, Hales CN, Lithell HO, Berne C. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care. 2004, 27:1433-8. 10.2337\/diacare.27.6.1433","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1430251","article-title":"Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes","volume":"143","author":"Vauhkonen IK","year":"2000","unstructured":"Vauhkonen IK, Niskanen LK, Mykk\u00e4nen L, Haffner SM, Uusitupa MI, Laakso M. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. Eur J Endocrinol. 2000, 143:251-60. 10.1530\/eje.0.1430251","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2322-2","article-title":"Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"54","author":"Loopstra-Masters RC","year":"2011","unstructured":"Loopstra-Masters RC, Haffner SM, Lorenzo C, Wagenknecht LE, Hanley AJ. Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetologia. 2011, 54:3047-54. 10.1007\/s00125-011-2322-2","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01634-1","article-title":"The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study","volume":"58","author":"Dario T","year":"2021","unstructured":"Dario T, Riccardo G, Silvia P, et al.. The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study. Acta Diabetol. 2021, 58:411-7. 10.1007\/s00592-020-01634-1","journal-title":"Acta Diabetol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist E","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, et al.. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018, 6:361-9. 10.1016\/S2213-8587(18)30051-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00948-2","article-title":"Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes","volume":"53","author":"Mansour Aly D","year":"2021","unstructured":"Mansour Aly D, Dwivedi OP, Prasad RB, et al.. Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes. Nat Genet. 2021, 53:1534-42. 10.1038\/s41588-021-00948-2","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler AE","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003, 52:102-10. 10.2337\/diabetes.52.1.102","journal-title":"Diabetes"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020735","article-title":"Selective \u03b2-cell loss and \u03b1-cell expansion in patients with type 2 diabetes mellitus in Korea","volume":"88","author":"Yoon KH","year":"2003","unstructured":"Yoon KH, Ko SH, Cho JH, et al.. Selective \u03b2-cell loss and \u03b1-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003, 88:2300-8. 10.1210\/jc.2002-020735","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0699","article-title":"Sulfonylurea induced beta-cell apoptosis in cultured human islets","volume":"90","author":"Maedler K","year":"2005","unstructured":"Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY. Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab. 2005, 90:501-6. 10.1210\/jc.2004-0699","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0258","article-title":"Markers of \u03b2-cell failure predict poor glycemic response to GLP-1 receptor agonist therapy in type 2 diabetes","volume":"39","author":"Jones AG","year":"2016","unstructured":"Jones AG, McDonald TJ, Shields BM, Hill AV, Hyde CJ, Knight BA, Hattersley AT. Markers of \u03b2-cell failure predict poor glycemic response to GLP-1 receptor agonist therapy in type 2 diabetes. Diabetes Care. 2016, 39:250-7. 10.2337\/dc15-0258","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro AM","year":"2006","unstructured":"Shapiro AM, Ricordi C, Hering BJ, et al.. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006, 355:1318-30. 10.1056\/NEJMoa061267","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2190","article-title":"Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual \u03b2-cell function","volume":"35","author":"Sherr J","year":"2012","unstructured":"Sherr J, Tamborlane WV, Xing D, et al.. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual \u03b2-cell function. Diabetes Care. 2012, 35:817-20. 10.2337\/dc11-2190","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-12-6","article-title":"Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin","volume":"12","author":"Jones AG","year":"2012","unstructured":"Jones AG, Besser RE, Shields BM, McDonald TJ, Hope SV, Knight BA, Hattersley AT. Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin. BMC Endocr Disord. 2012, 12:6. 10.1186\/1472-6823-12-6","journal-title":"BMC Endocr Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones AG","year":"2013","unstructured":"Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013, 30:803-17. 10.1111\/dme.12159","journal-title":"Diabet Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238764-c-peptide-level-in-patients-with-uncontrolled-type-2-diabetes-mellitus-on-oral-anti-diabetic-drugs","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T10:23:28Z","timestamp":1711275808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238764-c-peptide-level-in-patients-with-uncontrolled-type-2-diabetes-mellitus-on-oral-anti-diabetic-drugs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.56810","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,24]]}}}